Industry News

Valeant Pharmaceuticals International, Inc. today announced that the Board of Directors has appointed Ms. Sarah B. Kavanagh to serve as a director of the Board, effective July 22, 2016. With these changes, Valeant has increased the size of its board to 12 members, 11 of whom are independent."/>
Valeant Pharmaceuticals Announces The Addition Of Sarah B. Kavanagh To Its Board Of Directors
Teligent, Inc., a New Jersey-based specialty generic pharmaceutical company, today announced its financial results for the second quarter ended June 30, 2016.. Total revenues of $17.1 million in the second quarter of 2016, an increase of 93% over the same quarter in 2015. Total net revenues generated from the sale of our generic topical and injectable pharmaceutical products for the three months ended June 30, 2016 and 2015 of $11.1 million..."/>
Teligent, Inc. Announces Second Quarter 2016 Results
Sequenom, Inc. in a cash tender offer of USD 2.40 per share, or an equity value of USD 302 m, the company said. The price represents a total enterprise value of approximately USD 371 m, including net indebtedness. Under the terms of the agreement and plan of merger, LabCorp has formed an acquisition subsidiary, Savoy..."/>
LabCorp Agrees to Acquire Genone Interpretation Specialist Sequenom in USD 302m Deal
American Renal Associates, Inc. violated applicable laws by causing the company to engage in health insurance fraud. American Renal Associates operates as a dialysis services provider in the United States focused exclusively on joint venture partnerships with physicians. View this press release on the law firm's Shareholder Rights Blog:..."/>
Robbins Arroyo LLP Is Investigating the Officers and Directors of American Renal Associates Holdings, Inc. (ARA) on Behalf of Shareholders
China Cord Blood Corporation, China's leading provider of cord blood collection, laboratory testing, hematopoietic stem cell processing, and stem cell storage services, today announced that the Company filed its Annual Report on Form 20- F with the U.S. The filed Form 20- F includes audited financial statements for the fiscal year ended March 31, 2016. The Form 20- F can be accessed by visiting the U.S."/>
China Cord Blood Corporation Files Its Annual Report on Form 20-F
Quidel Corporation, a provider of rapid diagnostic testing solutions, cellular-based virology assays and molecular diagnostic systems, announced today that it will present at the 36 th Annual Canaccord Genuity Growth Conference, to be held at the InterContinental Boston hotel in Boston, Massachusetts on Wednesday, August 10, 2016.. Douglas Bryant, president and chief executive officer, and Randy Steward, chief financial officer, will present that day at..."/>
Quidel to Present at the 36th Annual Canaccord Genuity Growth Conference
Mallinckrodt plc, a leading global specialty pharmaceutical company, today confirmed enrollment of the first patient in the company's Phase 3 clinical study to evaluate the efficacy and safety of terlipressin in subjects with Hepatorenal Syndrome type 1.. "Patients diagnosed with HRS type 1 typically have a very poor prognosis, and there is a significant unmet need for an approved treatment," said lead investigator..."/>
First Patient Enrolled in Mallinckrodt Phase 3 Terlipressin Trial
Otonomy, Inc., a biopharmaceutical company focused on the development and commercialization of innovative therapeutics for diseases and disorders of the ear, today announced it will report financial results for the second quarter 2016 as well as provide a corporate update at 4:30 p.m. EDT on August 4, 2016.. The live call may be accessed by dialing 305-6769 for domestic callers and 562-4239 for international callers with conference ID code number:..."/>
Otonomy to Report Second Quarter 2016 Financial Results and Provide Corporate Update
HealthSouth Corporation, one of the nation's largest providers of post-acute healthcare services, offering both facility-based and home-based post-acute services, today reported its results of operations for the second quarter ended June 30, 2016.. "The second quarter was another strong quarter for HealthSouth with volume, revenue, and earnings from our recent acquisitions complementing solid organic growth," said Jay Grinney,..."/>
HealthSouth Reports Strong Revenue, Volume, and Earnings Growth for Second Quarter 2016 and Raises Full-Year 2016 Guidance
Focus on filgotinib and cystic fibrosis
Quality Systems, Inc. announced today results for its fiscal 2017 first quarter ended June 30, 2016.. “In the first quarter, we saw a number of positive developments as we continued to execute on our strategic plan and have made great progress reinvigorating the culture of our organization,” commented Rusty Frantz, president and chief executive officer of Quality Systems, Inc.“ In addition, we remain focused on our solutions integration and product roadmap..."/>
Quality Systems, Inc. Reports Fiscal 2017 First Quarter Results
BD Names R. Andrew Eckert To Board Of Directors
Vocera Communications, Inc., a leading healthcare communications company, today reported total revenue of $31.2 million, an increase of 22% compared to revenue of $25.4 million in the second quarter of 2015.. “The second quarter of 2016 was another strong quarter for our business. The market for our products is expanding, and our platform offering is resonating with customers who are looking for solutions to solve communication and collaboration..."/>
Vocera Announces Second Quarter Revenue of $31.2 million and Raises FY’16 Guidance
ATI Airtest Technologies Inc.. Resumption: July 29, 2016, 08:00 AM."/>
IIROC Trading Resumption - AAT; APH
Omnicell, Inc. today announced that Rochester Regional Health, a five-hospital health system in western New York, has selected the Company's medication automation solutions for its hospital floors and operating rooms to promote the highest level of patient care. Formed in 2014, Rochester Regional is currently installing Omnicell ® automated medication dispensing systems in two of its five hospitals that collectively serve..."/>
Omnicell Selected to Provide Interoperable Medication Automation Solutions to Support Patient Safety at Rochester Regional Health
Agile Therapeutics, Inc., today announced the appointment of Seth H. Z. Fischer to the Company's Board of Directors, effective July 28, 2016. Fischer will serve on Agile’ s Compensation and Nominating& Corporate Governance Committees.. “We are very pleased to welcome Seth to our board of directors,” stated Al Altomari, President and Chief Executive Officer of Agile.“ Seth’ s significant commercial background, including expertise in leading and developing..."/>
Agile Therapeutics Appoints Seth H. Z. Fischer to its Board of Directors
Mettler-Toledo International Inc. today announced second quarter results for 2016. Provided below are the highlights:. Sales in local currency increased 6% in the quarter compared with the prior year."/>
Mettler-Toledo International Inc. Reports Second Quarter 2016 Results
Quotient Limited, a commercial-stage diagnostics company, today announced that it intends to commence an underwritten public offering of its ordinary shares.. Jefferies LLC is acting as sole bookrunner for the offering. This press release shall not constitute an offer to sell or the solicitation of an offer to buy nor shall there be any sale of these securities in any state or jurisdiction in which such offer, solicitation or sale would be..."/>
Quotient Limited Announces Proposed Underwritten Offering of Ordinary Shares
Vocera Communications, Inc., the leading healthcare communications company, today announced that Alexa King, executive vice president and general counsel at FireEye, joined Vocera’ s Board of Directors effective July 27, 2016.. Since 2012, King has led the legal team at FireEye, the leading security platform that provides real-time threat protection to enterprises and governments worldwide against the next generation of cyber-attacks."/>
FireEye EVP and General Counsel Alexa King Joins Vocera Board of Directors
AcelRx Pharmaceuticals, Inc.,, a specialty pharmaceutical company focused on the development and commercialization of innovative therapies for the treatment of acute pain, today provided a corporate update and reported financial results for the three and six months ended June 30, 2016.. ARX-04 Clinical and Commercial Update:. AcelRx completed enrollment in two Phase 3 studies: SAP302, which treated a total of 76 patients who..."/>
AcelRx Pharmaceuticals Provides Corporate Update and Reports Second Quarter and Six Months 2016 Financial Results
Pfizer Inc. announced today top-line results from Oral Clinical Trials for tofAcitinib in ulceratiVE colitis Sustain, the third Phase 3 study of XELJANZ ® being investigated in patients with moderately to severely active ulcerative colitis. OCTAVE Sustain is a 52 week study that evaluated oral tofacitinib 5 mg and 10 mg twice daily as a maintenance treatment in adult patients with moderately to severely active UC who previously completed and achieved clinical..."/>
Pfizer Announces Positive Top-Line Results from Pivotal Phase 3 Maintenance Trial of Oral XELJANZ® (Tofacitinib Citrate) in Ulcerative Colitis
Dicerna Pharmaceuticals, Inc., a leading developer of investigational RNA interference therapeutics, today announced that the Company will release its second quarter 2016 financial results after market close on Thursday, August 4, 2016.. Management will conduct a conference call at 4:30 p.m. ET that day to discuss the Company's financial results and provide a general business update. The conference call will be webcast live via the Internet and will be..."/>
Dicerna to Report Second Quarter 2016 Financial Results and Host Conference Call on August 4, 2016
OvaScience SM, a global fertility company focused on the discovery, development and commercialization of new treatment options, announced today that it will host a conference call at 4:30 p.m. EDT on Thursday, August 4, 2016 to discuss second quarter 2016 financial results and provide a general corporate update. The live call can be accessed by dialing +1-888-424-8151 for U.S. callers and +1-847-585-4422 for international callers five minutes prior to the..."/>
OvaScience to Host Second Quarter 2016 Financial Results Conference Call
Alliance HealthCare Services announced today that it will host a conference call and webcast on Thursday, August 4, 2016, at 5 p.m. Eastern Time, to discuss the Company’ s second quarter 2016 financial results, which are scheduled to be released after the market closes on Thursday, August 4, 2016. Tom Tomlinson, Chief Executive Officer and President, is scheduled to host the call."/>
Alliance HealthCare Services Schedules Conference Call for Second Quarter 2016 Financial Results
Innoviva, Inc. today reported financial results for the second quarter ended June 30, 2016."/>
Innoviva Reports Second Quarter 2016 Financial Results

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Most Popular Sectors in the News
Sectors Articles in the last 7 days
Financials949 Articles
Information Technology904 Articles
Consumer Discretionary760 Articles
Industrials603 Articles
Health Care596 Articles

Sponsored Financial Commentaries

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact , please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at